ENGEL JB[au] - Search Results

Year	Number of Results
1984	1
2001	1
2002	3
2003	3
2005	14
2006	5
2007	5
2008	4
2009	6
2010	8
2011	8
2012	7
2013	4
2014	6
2015	5
2016	2
2017	3
2019	1
2022	1
2024	0

1

Engel JB. Engel JB. Oncotarget. 2015 Feb 10;6(4):1898-9. doi: 10.18632/oncotarget.3271. Oncotarget. 2015. PMID: 25655918 Free PMC article. No abstract available.

2

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer.

Engel JB, Tinneberg HR, Rick FG, Berkes E, Schally AV. Engel JB, et al. Curr Drug Targets. 2016;17(5):488-94. doi: 10.2174/138945011705160303154717. Curr Drug Targets. 2016. PMID: 26951061 Review.

3

The role of regulatory T cells in ovarian cancer.

Dietl J, Engel JB, Wischhusen J. Dietl J, et al. Among authors: engel jb. Int J Gynecol Cancer. 2007 Jul-Aug;17(4):764-70. doi: 10.1111/j.1525-1438.2006.00861.x. Epub 2007 Feb 16. Int J Gynecol Cancer. 2007. PMID: 17309663 Review.

4

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.

Schally AV, Varga JL, Engel JB. Schally AV, et al. Among authors: engel jb. Nat Clin Pract Endocrinol Metab. 2008 Jan;4(1):33-43. doi: 10.1038/ncpendmet0677. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18084344 Review.

5

Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).

Engel JB, Schally AV, Buchholz S, Seitz S, Emons G, Ortmann O. Engel JB, et al. Arch Gynecol Obstet. 2012 Aug;286(2):437-42. doi: 10.1007/s00404-012-2335-1. Epub 2012 May 4. Arch Gynecol Obstet. 2012. PMID: 22555802 Review.

6

Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.

Engel JB, Schally AV. Engel JB, et al. Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):157-67. doi: 10.1038/ncpendmet0399. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17237842 Review.

7

Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors.

Schally AV, Engel JB, Emons G, Block NL, Pinski J. Schally AV, et al. Among authors: engel jb. Curr Drug Deliv. 2011 Jan;8(1):11-25. doi: 10.2174/156720111793663598. Curr Drug Deliv. 2011. PMID: 21034424 Review.

8

Immune escape of AKT overexpressing ovarian cancer cells.

Hahne JC, Meyer SR, Gambaryan S, Walter U, Dietl J, Engel JB, Honig A. Hahne JC, et al. Among authors: engel jb. Int J Oncol. 2013 May;42(5):1630-5. doi: 10.3892/ijo.2013.1846. Epub 2013 Mar 4. Int J Oncol. 2013. PMID: 23467686

9

Making the reuse of agro-industrial wastes a reality for starch-based packaging sector: A storage case study of carrot cake and cherry tomatoes.

Engel JB, Luchese CL, Tessaro IC. Engel JB, et al. Int J Biol Macromol. 2022 May 1;206:740-749. doi: 10.1016/j.ijbiomac.2022.03.074. Epub 2022 Mar 16. Int J Biol Macromol. 2022. PMID: 35306011 Free article.

10

Pleomorphic adenoma of the breast initially misdiagnosed as metaplastic carcinoma in preoperative stereotactic biopsy: a case report and review of the literature.

Djakovic A, Engel JB, Geisinger E, Honig A, Tschammler A, Dietl J. Djakovic A, et al. Among authors: engel jb. Eur J Gynaecol Oncol. 2011;32(4):427-30. Eur J Gynaecol Oncol. 2011. PMID: 21941969 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year